Promissory Note Between Sybleu Inc. and Zander Therapeutics, Inc. (10% Interest, $5,500, Due October 16, 2024)
Sybleu Inc. has borrowed $5,500 from Zander Therapeutics, Inc. under a promissory note with a 10% annual simple interest rate. The full amount, including interest, is due to be repaid by October 16, 2024. The note can be repaid early without penalty. The agreement is governed by California law, and Sybleu Inc. remains responsible for repayment even if the note is transferred to another party.
PROMISSORY NOTE (“NOTE”) - 10% SIMPLE INTEREST $5,500
For VALUE RECEIVED, SYBLEU INC. (“Borrower”) promises to pay to Zander Therapeutics, Inc. (“Lender”) the principal sum of Five Thousand Five Hundred ($5,500) with accrued simple interest at the rate of 10% percent per annum on the balance. The said principal and accrued interest shall be payable in lawful money of the United States of America on October 16, 2024. This Note may be prepaid in whole or in part at any time without premium or penalty. The Borrower hereby waives any notice of the transfer of this Note by the Lender or by any subsequent holder of this Note, agrees to remain bound by the terms of this Note subsequent to any transfer, and agrees that the terms of this Note may be fully enforced by any subsequent holder of this Note. All terms and conditions of this Note shall be interpreted under the laws of the state of California and venue shall be the state of California.
SYBLEU INC.
By: /s/Joseph G Vaini
Its: Chairman and CEO
Accepted By:
Zander Therapeutics, Inc.
By:/s/David Koos
Its: Chairman
